MRD Monitoring in Acute Lymphoblastic Leukemia
0 Visualizzazioni
administrator
06/15/23
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Mostra di più
Commenti su Facebook
Nessun commento trovato